Q32 Bio (QTTB) director awarded 9,810 stock options at $12.64 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Q32 Bio Inc. director Arthur Tzianabos received a grant of stock options representing 9,810 shares of common stock. The options have an exercise price of $12.64 per share and expire on June 11, 2036. Following this grant, he holds 9,810 options directly from this award in this filing.
According to the vesting terms, these options will vest and become exercisable in full on the earlier of June 12, 2027 or the date of Q32 Bio’s next annual meeting of stockholders, provided he continues to serve with the company through the applicable vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
TZIANABOS ARTHUR
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,810 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 9,810 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 9,810 options
Exercise price: $12.64 per share
Expiration date: June 11, 2036
+1 more
4 metrics
Options granted
9,810 options
Stock Option (Right to Buy) grant
Exercise price
$12.64 per share
Stock option strike price
Expiration date
June 11, 2036
Option term end
Underlying shares
9,810 shares
Common stock underlying options
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vest and become exercisable
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 12.6400"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-11T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest and become exercisable financial
"The shares underlying this option shall vest and become exercisable in full"
FAQ
What did Q32 Bio (QTTB) director Arthur Tzianabos report in this Form 4?
Arthur Tzianabos reported receiving a grant of stock options for 9,810 shares of Q32 Bio common stock. These options were awarded as compensation and give him the right to buy shares at a fixed exercise price if vesting conditions are met.
How many Q32 Bio (QTTB) options were granted and at what exercise price?
The filing shows a grant of stock options covering 9,810 underlying Q32 Bio common shares with an exercise price of $12.64 per share. This price is the cost per share if he later chooses to exercise the options after they vest.
When do Arthur Tzianabos’s Q32 Bio (QTTB) stock options vest?
The options will vest and become exercisable in full on the earlier of June 12, 2027, or the date of Q32 Bio’s next annual stockholder meeting. Vesting requires his continued service with the company through that vesting date.
What is the expiration date of the Q32 Bio (QTTB) options granted to Arthur Tzianabos?
The granted stock options expire on June 11, 2036. After this expiration date, any unexercised options cease to be usable, so exercising can only occur between vesting and the stated expiration, subject to applicable company and plan rules.